US2003119824A1PendingUtilityA1

Treatment of inflammatory bowel disease

59
Priority: Jan 5, 2000Filed: Dec 19, 2002Published: Jun 26, 2003
Est. expiryJan 5, 2020(expired)· nominal 20-yr term from priority
Inventors:H. RedmondRolf W. Pfirrmann
A61K 31/549A61K 31/00A61P 1/04A61P 1/00
59
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Patients suffering from inflammatory bowel disease such as Crohn's disease or ulcerative colitis are treated either orally or intravenously with methylol transfer agents, such as taurolidine and/or taurultam. These agents can be used in combination with other drugs thereby allowing the use of smaller amounts of the other drugs and limiting unwanted side effects.

Claims

exact text as granted — not AI-modified
What is claimed is:  
     
         1 . A method of treating a human infected with Crohn's disease comprising orally administering to an individual in need of such treatment an effective amount of a composition comprising taurolidine.  
     
     
         2 . A method according to  claim 1  wherein the composition is in suspension form.

Join the waitlist — get patent alerts

Track US2003119824A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.